<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">41214136</PMID><DateRevised><Year>2025</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Nov</Month><Day>10</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Proteomic changes induced by acute exercise and high-intensity interval training during pregnancy: a pilot randomised controlled trial.</ArticleTitle><Pagination><StartPage>39317</StartPage><MedlinePgn>39317</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-025-22991-3</ELocationID><Abstract><AbstractText>Physical activity is essential for maternal health during pregnancy, with WHO guidelines recommending at least 150&#xa0;min of moderate-intensity aerobic physical activity per week. However, there is a lack of data on the impact of higher-intensity exercise during pregnancy, including the potential health effects of high-intensity interval training (HIIT). In this study, we aimed to analyse the changes induced by a cardiopulmonary exercise test (CPET) up to volitional exhaustion and an 8-week HIIT program on the urine proteome of pregnant women, using the SWATH-MS technique and provide insights into molecular processes influenced by HIIT. We recruited 18 women with uncomplicated singleton pregnancies between 13 and 28 weeks of gestation. All women underwent CPET to assess their peak oxygen uptake (VO2 peak), oxygen uptake at the anaerobic threshold (VO2/AT), and heart rate at the anaerobic threshold (HR/AT). Of these women, 9 participated in HIIT sessions three times for 8 weeks and were encouraged to exceed their HR/AT during the exercise intervals. Furthermore, nine women in the EDU group attended educational classes once a week and were advised to engage in moderate to vigorous physical activity independently, in accordance with current recommendations. We observed significant alterations in the urinary proteome after the CPET, with a higher scale of differentially expressed proteins compared to the changes observed after 8 weeks of the HIIT program. Notable changes included proteins involved in calcium ion binding, enzyme inhibitory activity, and immune system pathways, particularly neutrophil degranulation. Proteins such as ARSA, NPC2, MME, and CD177 showed significant regulation, indicating metabolic adaptations and immune responses. The observed downregulation of proteins, such as TFF2, associated with insulin resistance, suggests that HIIT may have potential benefits in preventing gestational diabetes. Our findings demonstrate that while CPET induces immediate metabolic and immune changes, regular HIIT leads to adaptations, reflected in a decrease in the number of altered proteins over time. Further studies are needed to confirm these findings and explore the long-term benefits of HIIT for pregnant women. Nevertheless, this pilot research provides a novel proteomic perspective on the impact of HIIT during pregnancy, underscoring its potential to improve maternal health through targeted metabolic and immune system adaptations.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Goik</LastName><ForeName>Dominka</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Mass Spectrometry, Intercollegiate Faculty of Biotechnology, University of Gdansk, Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szumilewicz</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3777-5697</Identifier><AffiliationInfo><Affiliation>Gdansk University of Physical Education and Sport, Gdansk, Poland. Anna.Szumilewicz@awf.gda.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musia&#x142;</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Mass Spectrometry, Intercollegiate Faculty of Biotechnology, University of Gdansk, Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos-Rocha</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Sport Sciences School of Rio Maior, Polytechnic Institute of Santar&#xe9;m, Rio Maior, Portugal.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SPRINT Sport Physical Activity and Health Research &amp; Innovation Centre, Santar&#xe9;m, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wo&#x142;yniec</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Occupational, Metabolic and Internal Diseases, Faculty of Health Sciences, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Gda&#x144;sk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>May</LastName><ForeName>Linda E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Kinesiology, East Carolina University, Greenville, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czaplewska</LastName><ForeName>Paulina</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6469-6014</Identifier><AffiliationInfo><Affiliation>Laboratory of Mass Spectrometry, Intercollegiate Faculty of Biotechnology, University of Gdansk, Gdansk, Poland. Paulina.Czaplewska@ug.edu.pl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HIIT</Keyword><Keyword MajorTopicYN="N">Mass spectrometry</Keyword><Keyword MajorTopicYN="N">Physical activity</Keyword><Keyword MajorTopicYN="N">Pregnancy</Keyword><Keyword MajorTopicYN="N">Urine samples</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>11</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>11</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>10</Day><Hour>23</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41214136</ArticleId><ArticleId IdType="doi">10.1038/s41598-025-22991-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-025-22991-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bull, F. C. et al. World health organization 2020 guidelines on physical activity and sedentary behaviour. Br. J. Sports Med. 54 (24), 1451&#x2013;1462. https://doi.org/10.1136/bjsports-2020-102955 (2020). PMID: 33239350; PMCID: PMC7719906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2020-102955</ArticleId><ArticleId IdType="pubmed">33239350</ArticleId></ArticleIdList></Reference><Reference><Citation>Thangaratinam, S. et al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: meta-analysis of randomised evidence. BMJ 344, e2088. https://doi.org/10.1136/bmj.e2088 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e2088</ArticleId><ArticleId IdType="pubmed">22596383</ArticleId><ArticleId IdType="pmc">3355191</ArticleId></ArticleIdList></Reference><Reference><Citation>Barakat, R., Pelaez, M., Montejo, R., Refoyo, I. &amp; Coteron, J. Exercise throughout pregnancy does not cause preterm delivery: A randomised, controlled trial. J. Phys. Act. Health. 11 (6), 1012&#x2013;1017 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1123/jpah.2012-0344</ArticleId><ArticleId IdType="pubmed">23676311</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport, M. H. et al. Impact of prenatal exercise on maternal harms, labour and delivery outcomes: a systematic review and meta-analysis. Br. J. Sports Med. https://doi.org/10.1136/bjsports-2018-099821 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2018-099821</ArticleId><ArticleId IdType="pubmed">30337466</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport, M. H. et al. Impact of prenatal exercise on neonatal and childhood outcomes: a systematic review and meta-analysis. Br. J. Sports Med. 52 (21), 1386&#x2013;1396 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2018-099836</ArticleId><ArticleId IdType="pubmed">30337465</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport, M. H. et al. Prenatal exercise for the prevention of gestational diabetes mellitus and hypertensive disorders of pregnancy: a systematic review and meta-analysis. Br. J. Sports Med. 52 (21), 1367&#x2013;1375 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2018-099355</ArticleId><ArticleId IdType="pubmed">30337463</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruchat, S-M. et al. Effectiveness of exercise interventions in the prevention of excessive gestational weight gain and postpartum weight retention: a systematic review and meta-analysis. Br. J. Sports Med. 52 (21), 1347&#x2013;1356 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2018-099399</ArticleId><ArticleId IdType="pubmed">30337461</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler, C., Williams, M., Sorensen, T., Frederick, I. &amp; Leisenring, W. Relation between maternal recreational physical activity and plasma lipids in early pregnancy. Am. J. Epidemiol. 160, 350&#x2013;359 (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwh223</ArticleId><ArticleId IdType="pubmed">15286020</ArticleId></ArticleIdList></Reference><Reference><Citation>He, L. et al. The impact of physical activity intervention on perinatal depression: A systematic review and meta-analysis. J. Affect. Disord. 321, 304&#x2013;319 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2022.10.026</ArticleId><ArticleId IdType="pubmed">36374719</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardsen, K. R. et al. Predicting who fails to Meet the physical activity guideline in pregnancy: A prospective study of objectively recorded physical activity in a population-based multi-ethnic cohort. BMC Pregnancy Childbirth. 16 (1), 186. https://doi.org/10.1186/s12884-016-0985-x (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12884-016-0985-x</ArticleId><ArticleId IdType="pubmed">27460363</ArticleId><ArticleId IdType="pmc">4962490</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison, A. L., Taylor, N. F., Shields, N. &amp; Frawley, H. C. Attitudes, barriers and enablers to physical activity in pregnant women: A systematic review. J. Physiotherapy. 64 (1), 24&#x2013;32. https://doi.org/10.1016/j.jphys.2017.11.012 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphys.2017.11.012</ArticleId></ArticleIdList></Reference><Reference><Citation>de Castro, R., Antunes, R., Mendes, D., Szumilewicz, A. &amp; Santos-Rocha, R. Can Group Exercise Programs Improve Health Outcomes in Pregnant Women? An Updated Systematic Review. Int. J. Environ. Res. Public Health https://doi.org/10.3390/ijerph19084875 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19084875</ArticleId><ArticleId IdType="pubmed">36612736</ArticleId><ArticleId IdType="pmc">9819401</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood, G. et al. HIIT is not superior to MICT in altering blood lipids: a systematic review and meta-analysis. BMJ Open. Sport Exerc. Med. 5, e000647. https://doi.org/10.1136/bmjsem-2019-000647 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjsem-2019-000647</ArticleId><ArticleId IdType="pubmed">31921439</ArticleId><ArticleId IdType="pmc">6937112</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson Julie, P. et al. Acute fetal response to high-intensity interval training in the second and third trimesters of pregnancy. Appl. Physiol. Nutr. Metab. 46 (12), 1552&#x2013;1558. https://doi.org/10.1139/apnm-2020-1086 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/apnm-2020-1086</ArticleId><ArticleId IdType="pubmed">34433004</ArticleId></ArticleIdList></Reference><Reference><Citation>Wowdzia, J., Hazell, T. &amp; Davenport, M. Glycemic response to acute high-intensity interval versus moderate-intensity continuous exercise during pregnancy. Physiol. Rep. https://doi.org/10.14814/phy2.15454. (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.15454.</ArticleId><ArticleId IdType="pubmed">36117457</ArticleId><ArticleId IdType="pmc">9483614</ArticleId></ArticleIdList></Reference><Reference><Citation>Wowdzia, J. B. et al. Maternal and fetal cardiovascular responses to acute High-Intensity interval and Moderate-Intensity continuous training exercise during pregnancy: A randomised crossover trial. Sports Med. 53 (9), 1819&#x2013;1833 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40279-023-01858-5</ArticleId><ArticleId IdType="pubmed">37213048</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, H. L. et al. Effects of 8-Week Online, Supervised High-Intensity Interval Training on the Parameters Related to the Anaerobic Threshold, Body Weight, and Body Composition during Pregnancy: A Randomized Controlled Trial. Nutrients https://doi.org/10.3390/nu14245279 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14245279</ArticleId><ArticleId IdType="pubmed">36615821</ArticleId><ArticleId IdType="pmc">9824881</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, J., Radziminski, L., Santos-Rocha, R. &amp; Szumilewicz, A. High-intensity interval training is an effective exercise mode to maintain normal blood pressure during pregnancy: a randomised control trial. Sci. Rep. https://doi.org/10.1038/s41598-024-79552-3 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-79552-3</ArticleId><ArticleId IdType="pubmed">39739106</ArticleId><ArticleId IdType="pmc">11686368</ArticleId></ArticleIdList></Reference><Reference><Citation>Szumilewicz, A., Sun, J., Santos-Rocha, R., Mieszkowski, J. &amp; Kochanowicz, A. Changes in insulin, leptin, Resistin and Irisin Levels and their Associations with Blood Pressure after an 8-week supervised, Online HIIT aaMm Program vs. self-performed moderate-to-vigorous Physical Activity during pregnancy-A Randomised Controlled Trial.&#xa0;Baltic J. Health Phys. Act., 17 (2) (2025).</Citation></Reference><Reference><Citation>Barakat, R., Refoyo, I., Coteron, J. &amp; Franco, E. Exercise during pregnancy has a preventative effect on excessive maternal weight gain and gestational diabetes. A randomised controlled trial. *Brazilian J. Phys. Therapy 23(2), 148&#x2013;155. https://doi.org/10.1016/j.bjpt.2018.11.005 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjpt.2018.11.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, J. et al. Urinary proteomic and non-prefractionation quantitative phosphoproteomic analysis during pregnancy and non-pregnancy. BMC Genom. 14, 777. https://doi.org/10.1186/1471-2164-14-777 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-14-777</ArticleId></ArticleIdList></Reference><Reference><Citation>MacInnis, M. J. &amp; Gibala, M. J. Physiological adaptations to interval training and the role of exercise intensity. J. Physiol. 595, 2915&#x2013;2930. https://doi.org/10.1113/JP273196 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP273196</ArticleId><ArticleId IdType="pubmed">27748956</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilczynska, D., Walczak-Kozlowska, T., Santos-Rocha, R., Laskowski, R. &amp; Szumilewicz, A. Stress is not so bad-cortisol level and psychological functioning after 8-week HIIT program during pregnancy: a randomised controlled trial. Front. Public. Health https://doi.org/10.3389/fpubh.2023.1307998 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1307998</ArticleId><ArticleId IdType="pubmed">38259751</ArticleId><ArticleId IdType="pmc">10800893</ArticleId></ArticleIdList></Reference><Reference><Citation>Szumilewicz, A. et al. Translation and cross-cultural adaptation of the Get Active Questionnaire for Pregnancy (kwestionariusz Bad&#x17a; Aktywna w Ci&#x105;&#x17c;y) to support physical activity among pregnant women in Poland. Ginekol. Pol. https://doi.org/10.1016/j.apunsm.2024.100463 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apunsm.2024.100463</ArticleId><ArticleId IdType="pubmed">38334341</ArticleId></ArticleIdList></Reference><Reference><Citation>Szumilewicz, A. et al. Acute Postexercise Change in Circulating Irisin Is Related to More Favorable Lipid Profile in Pregnant Women Attending a Structured Exercise Program and to Less Favorable Lipid Profile in Controls: An Experimental Study with Two Groups. Intern. J. Endocrinol. https://doi.org/10.1155/2019/1932503 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/1932503</ArticleId></ArticleIdList></Reference><Reference><Citation>Szumilewicz, A. et al. How to HIIT while pregnant? The protocols characteristics and effects of high intensity interval training implemented during pregnancy - a systematic review. Baltic J. Phys. Activity Health. 14 (1), 1&#x2013;16 (2022).</Citation></Reference><Reference><Citation>Beaver, W. L., Wasserman, K. &amp; Whipp, B. J. A new method for detecting anaerobic threshold by gas exchange. J. Appl. Physiol. 60(6), 2020&#x2013;7. https://doi.org/10.1152/jappl.1986.60.6.2020 (1986).</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1986.60.6.2020</ArticleId><ArticleId IdType="pubmed">3087938</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowska, E. et al. Polish Society of Gynecologists and Obstetricians (PTGiP) and Polish Society of Sports Medicine (PTMS) recommendations on physical activity during pregnancy and the postpartum period. Ginekol. Pol. https://doi.org/10.5603/GP.a2023.0080 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/GP.a2023.0080</ArticleId><ArticleId IdType="pubmed">37599577</ArticleId></ArticleIdList></Reference><Reference><Citation>Borg, G. Borg&#x2019;s perceived exertion and pain scales (Human Kinetics, 1998).</Citation></Reference><Reference><Citation>Persinger, R., Foster, C., Gibson, M., Fater, D. C. W. &amp; Porcari, J. P. Consistency of the talk test for exercise prescription. Med. Sci. Sports. Exerc. 36 (9), 1632&#x2013;1636 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15354048</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilczynska, D. et al. Can we hit prenatal depression and anxiety through HIIT? The effectiveness of online high intensity interval training in pregnant women during the COVID-19 pandemic: a randomised controlled trial. Bmc Sports Sci. Med. Rehabilitation https://doi.org/10.1186/s13102-022-00610-2 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13102-022-00610-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Wi&#x15b;niewski, J. R. Filter Aided Sample Preparation - A tutorial. Anal. Chim. Acta. 1090, 23&#x2013;30. https://doi.org/10.1016/j.aca.2019.08.032 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2019.08.032</ArticleId><ArticleId IdType="pubmed">31655642</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappsilber, J., Mann, M. &amp; Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2(8), 1896&#x2013;906. https://doi.org/10.1038/nprot.2007.261 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2007.261</ArticleId><ArticleId IdType="pubmed">17703201</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewandowska, A. E. et al. Human follicular fluid proteomic and peptidomic composition quantitative studies by SWATH-MS methodology. Applicability of high pH RP-HPLC fractionation. J. Proteomics 191, 131&#x2013;142. https://doi.org/10.1016/j.jprot.2018.03.010 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2018.03.010</ArticleId><ArticleId IdType="pubmed">29530678</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyanova, S. et al. The perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods. 13, 731&#x2013;740. https://doi.org/10.1038/nmeth.3901 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3901</ArticleId><ArticleId IdType="pubmed">27348712</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51(D1), D638&#x2013;D646. https://doi.org/10.1093/nar/gkac1000 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac1000</ArticleId><ArticleId IdType="pubmed">36370105</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. &amp; Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672&#x2013;D677 (2025).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkae909</ArticleId><ArticleId IdType="pubmed">39417505</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. &amp; Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457&#x2013;D462 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1070</ArticleId><ArticleId IdType="pubmed">26476454</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa, M. &amp; Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27&#x2013;30 (2000).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/28.1.27</ArticleId><ArticleId IdType="pubmed">10592173</ArticleId><ArticleId IdType="pmc">102409</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13 (11), 2498&#x2013;2504. https://doi.org/10.1101/gr.1239303 (2003).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId><ArticleId IdType="pmc">403769</ArticleId></ArticleIdList></Reference><Reference><Citation>Musia&#x142;, N. et al. Proteomic analysis of sialoliths from calcified, lipid and mixed groups as a source of potential biomarkers of deposit formation in the salivary glands. Clin. Proteom. 20 (1), 11. https://doi.org/10.1186/s12014-023-09402-3 (2023). PMID: 36949424; PMCID: PMC10035263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12014-023-09402-3.</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumenreich, S. et al. Large-scale proteomics analysis of five brain regions from parkinson&#x2019;s disease patients with a GBA1 mutation. Npj Parkinsons Dis. 10, 33. https://doi.org/10.1038/s41531-024-00645-x (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-024-00645-x</ArticleId><ArticleId IdType="pubmed">38331996</ArticleId><ArticleId IdType="pmc">10853186</ArticleId></ArticleIdList></Reference><Reference><Citation>Dammer, E. B. et al. Multi-platform proteomic analysis of alzheimer&#x2019;s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome. Alz Res. Therapy. 14, 174. https://doi.org/10.1186/s13195-022-01113-5 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-022-01113-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Kardel, K. R. Effects of intense training during and after pregnancy in top-level athletes. Scand. J. Med. Sci. Sports. 15 (2), 79&#x2013;86 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0838.2004.00426.x</ArticleId><ArticleId IdType="pubmed">15773861</ArticleId></ArticleIdList></Reference><Reference><Citation>Halse, R. E., Wallman, K. E., Dimmock, J. A., Newnham, J. P. &amp; Guelfi, K. J. Home-Based exercise improves fitness and exercise attitude and intention in women with GDM. Med. Sci. Sports. Exerc. 47 (8), 1698&#x2013;1704 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/MSS.0000000000000587</ArticleId><ArticleId IdType="pubmed">25412300</ArticleId></ArticleIdList></Reference><Reference><Citation>Songstad, N. T. et al. Effects of high intensity interval training on pregnant Rats, and the Placenta, heart and liver of their fetuses. PLoS One 10(10), 1&#x2013;15 (2015).</Citation></Reference><Reference><Citation>Mohammadkhani, R., Khaledi, N., Rajabi, H., Salehi, I. &amp; Komaki, A. Influence of the maternal high-intensityinterval- training on the cardiac Sirt6 and lipid profile of the adult male offspring in rats. PLoS One https://doi.org/10.1371/journal.pone.0237148 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0237148</ArticleId><ArticleId IdType="pubmed">32745152</ArticleId><ArticleId IdType="pmc">7398538</ArticleId></ArticleIdList></Reference><Reference><Citation>Nov&#xe1;k, J. &amp; Stork, M. High fitness age as a risk factor for morbidity and premature mortality. Physiol. Res. 72, S489&#x2013;S97 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.33549/physiolres.935251</ArticleId><ArticleId IdType="pubmed">38165753</ArticleId><ArticleId IdType="pmc">10861247</ArticleId></ArticleIdList></Reference><Reference><Citation>Bako&#x144;ska-Paco&#x144;, E., Jethon, Z., Podhorska-Oko&#x142;&#xf3;w, M. &amp; Dziegiel, P. Changes of lysosomal enzymes activity in the skeletal muscle fibers exposed to endurance exercise. Rocz Akad. Med. Bialymst. 50 (Suppl. 1), 284&#x2013;287 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16119687</ArticleId></ArticleIdList></Reference><Reference><Citation>Drewa, G. et al. Influence of exercise on arylsulfatase and acid phosphatase activities in blood serum of kayakers and rowers,&#xa0;Biol. Sport&#xa0;17 289&#x2013;297 (2000).</Citation></Reference><Reference><Citation>Hill, E. E. et al. Exercise and circulating cortisol levels: The intensity threshold effect. J. Endocrinol. Invest. 31(7), 587&#x2013;591. https://doi.org/10.1007/BF03345606 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03345606</ArticleId><ArticleId IdType="pubmed">18787373</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr, B. R., Parker, C. R. Jr., Madden, J. D., MacDonald, P. C. &amp; Porter, J. C. Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy. American J. Obstet. Gynecol. 139(4), 416&#x2013;422. https://doi.org/10.1016/0002-9378(81)90318-5 (1981).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9378(81)90318-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Canibano-Fraile, R., Harlaar, L., Dos Santos, C. A., Hoogeveen-Westerveld, M., Demmers,J. A. A., Snijders, T., Schaaf, G. J. (2023). Lysosomal glycogen accumulation in Pompe disease results in disturbed cytoplasmic glycogen metabolism. J. Inherit. Metab. Dis., 46(1) 101&#x2013;115. https://doi.org/10.1002/jimd.12560.</Citation></Reference><Reference><Citation>Torres, S. et al. Lysosomal and Mitochondrial Liaisons in Niemann-Pick Disease. Front. Physiol. https://doi.org/10.3389/fphys.2017.00982 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2017.00982</ArticleId><ArticleId IdType="pubmed">29255420</ArticleId><ArticleId IdType="pmc">5723014</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou, H. L. et al. NPC2, the protein deficient in Niemann-Pick C2 Disease, consists of multiple glycoforms that bind a variety of sterols *&gt;. J. Biol. Chem. 281 (48), 36710&#x2013;36723. https://doi.org/10.1074/jbc.M608743200 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M608743200</ArticleId><ArticleId IdType="pubmed">17018531</ArticleId></ArticleIdList></Reference><Reference><Citation>Araki, N., Ishigami, T., Ushio, H., Minegishi, S., Umemura, M., Miyagi, Y., Umemura,S. (2009). Identification of NPC2 protein as interaction molecule with C2 domain of human Nedd4L. Biochem. Biophys. Res. Commun. 388(2) 290&#x2013;296 https://doi.org/10.1016/j.bbrc.2009.07.158.</Citation></Reference><Reference><Citation>Song, J., Zhu, N., Pan, X., Guo, L. &amp; Kong, X. Expression and significance of cathepsin C and cathepsin D during pregnancy and preeclampsia. Reproductive Biology Endocrinol. 21 (1), 92. https://doi.org/10.1186/s12958-023-01138-x (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12958-023-01138-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers, J. D., Kettritz, R. &amp; Korkmaz, B. Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease. Frontiers Immunol. 14, 1239151. https://doi.org/10.3389/fimmu.2023.1239151 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1239151</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick, P. A., Guinan, A. F., Walsh, T. G., Murphy, R. P., Killeen, M. T., Tobin,N. P., Cummins, P. M. (2009). Down-regulation of neprilysin (EC3.4.24.11) expression in vascular endothelial cells by laminar shear stress involves NADPH oxidase-dependent ROS production. The Intern. J. Biochem. Cell Biol., 41(11) 2287&#x2013;2294 https://doi.org/10.1016/j.biocel.2009.05.011</Citation></Reference><Reference><Citation>Jerke, U. et al. Characterisation of the CD177 interaction with the ANCA antigen proteinase 3. Sci. Rep. 7 (1), 43328. https://doi.org/10.1038/srep43328 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep43328</ArticleId><ArticleId IdType="pubmed">28240246</ArticleId><ArticleId IdType="pmc">5327412</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowland, J. B. &amp; Borregaard, N. Granulopoiesis and granules of human neutrophils. Immunol. Rev. 273 (1), 11&#x2013;28. https://doi.org/10.1111/imr.12440 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12440</ArticleId><ArticleId IdType="pubmed">27558325</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza, D. et al. Acute and chronic effects of interval training on the immune system: A systematic review with Meta-Analysis. Biology 10 (9), 868. https://doi.org/10.3390/biology10090868 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10090868</ArticleId><ArticleId IdType="pubmed">34571745</ArticleId><ArticleId IdType="pmc">8465842</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki, K. et al. Impact of a competitive marathon race on systemic cytokine and neutrophil responses. Med. Sci. Sports Exerc. 35(2), 348&#x2013;55. https://doi.org/10.1249/01.MSS.0000048861.57899.04 (2003).</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/01.MSS.0000048861.57899.04</ArticleId><ArticleId IdType="pubmed">12569227</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Canestro, C., Chen, J., Liu, Y., Han, H., Wang, Y., Honor&#xe9;, E. Xu, A. (2023).A machine-learning algorithm integrating baseline serum proteomic signatures predicts exercise responsiveness in overweight males with prediabetes. Cell Rep. Med., 4(2), 100944. https://doi.org/10.1016/j.xcrm.2023.100944.</Citation></Reference><Reference><Citation>Ghanemi, A., Yoshioka, M. &amp; St-Amand, J. Trefoil Factor Family Member 2 Expression as an Indicator of the Severity of the High-Fat Diet-Induced Obesity. Genes 12(10), 1505. https://doi.org/10.3390/genes12101505 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12101505</ArticleId><ArticleId IdType="pubmed">34680900</ArticleId><ArticleId IdType="pmc">8535368</ArticleId></ArticleIdList></Reference><Reference><Citation>De Giorgio, M. R. et al. Trefoil factor family member 2 (Tff2) KO mice are protected from high-fat diet-induced obesity. Obesity 21, 1389&#x2013;1395. https://doi.org/10.1002/oby.20165 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.20165</ArticleId><ArticleId IdType="pubmed">23754443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wo&#x142;yniec, W., Ratkowski, W., Renke, J. &amp; Renke, M. Changes in novel AKI biomarkers after Exercise. A systematic review. Int. J. Mol. Sci. 21 (16), 5673. https://doi.org/10.3390/ijms21165673 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21165673</ArticleId><ArticleId IdType="pubmed">32784748</ArticleId><ArticleId IdType="pmc">7461060</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamijo-Ikemori, A., Sugaya, T. &amp; Kimura, K. Urinary fatty acid binding protein in renal disease. Clin. Chim. Acta. 374 (1), 1&#x2013;7. https://doi.org/10.1016/j.cca.2006.05.038 (2006).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2006.05.038</ArticleId><ArticleId IdType="pubmed">16860300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamijo, A. et al. Urinary excretion of fatty Acid-Binding protein reflects stress overload on the proximal tubules. Am. J. Pathol. 165 (4), 1243&#x2013;1255. https://doi.org/10.1016/S0002-9440(10)63384-6 (2004).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)63384-6</ArticleId><ArticleId IdType="pubmed">15466390</ArticleId><ArticleId IdType="pmc">1618632</ArticleId></ArticleIdList></Reference><Reference><Citation>Devuyst, O. &amp; Olinger, E. Uromodulin: from physiology to rare and complex kidney disorders. Nat. Rev. Nephrol. 13 (7), 525&#x2013;544 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.101</ArticleId><ArticleId IdType="pubmed">28781372</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokonami, N. et al. Uromodulin is expressed in the distal convoluted tubule, where it is critical for regulation of the sodium chloride cotransporter NCC. Kidney Int. 94 (4), 701&#x2013;715. https://doi.org/10.1016/j.kint.2018.04.021 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2018.04.021</ArticleId><ArticleId IdType="pubmed">30007527</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, G., Lin, W., McAinch, A. J., Yan, &amp; Xu,. Identification of Urinary Biomarkers for Exercise-Induced Immunosuppression by iTR Proteomics. BioMed. Res. Intern. 2020, 3030793. https://doi.org/10.1155/2020/3030793 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/3030793</ArticleId></ArticleIdList></Reference><Reference><Citation>Teplan, V. et al. Early exercise training after renal transplantation and asymmetric dimethylarginine: the effect of obesity. Kidney Blood Press. Res. 39 (4), 289&#x2013;298. https://doi.org/10.1159/000355806 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000355806</ArticleId><ArticleId IdType="pubmed">25196348</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts, C. K., Barnard, R. J., Jasman, A. &amp; Balon, T. W. Acute exercise increases nitric oxide synthase activity in skeletal muscle. Am. J. Physiology-Endocrinology Metabolism. 277 (2), E390&#x2013;E394. https://doi.org/10.1152/ajpendo.1999.277.2.E390 (1999).</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.1999.277.2.E390</ArticleId></ArticleIdList></Reference><Reference><Citation>Mor&#xe9;n, A. et al. Identification and characterisation of LTBP-2, a novel latent transforming growth factor-beta-binding protein. J. Biol. Chem. 269 (51), 32469&#x2013;32478. https://doi.org/10.1016/S0021-9258(18)31659-4 (1994).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)31659-4</ArticleId><ArticleId IdType="pubmed">7798248</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirai, M. et al. Latent TGF-&#x3b2;&#x2010;binding protein 2 binds to DANCE/fibulin&#x2010;5 and regulates elastic fiber assembly. EMBO J. 26 (14), 3283&#x2013;3295. https://doi.org/10.1038/sj.emboj.7601768 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7601768</ArticleId><ArticleId IdType="pubmed">17581631</ArticleId><ArticleId IdType="pmc">1933399</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifkin, D. B. Latent transforming growth Factor-&#x3b2; (TGF-&#x3b2;) binding proteins: orchestrators of TGF-&#x3b2; Availability *. J. Biol. Chem. 280 (9), 7409&#x2013;7412. https://doi.org/10.1074/jbc.R400029200 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R400029200</ArticleId><ArticleId IdType="pubmed">15611103</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustin, M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell. Biol. 19(8), 5237&#x2013;5246. https://doi.org/10.1128/MCB.19.8.5237 (1999).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.19.8.5237</ArticleId><ArticleId IdType="pubmed">10409715</ArticleId><ArticleId IdType="pmc">84367</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustin, M. Chromatin unfolding and activation by HMGN chromosomal proteins. Trends Biochem. Sci. 26(7), 431&#x2013;437 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0968-0004(01)01855-2</ArticleId><ArticleId IdType="pubmed">11440855</ArticleId></ArticleIdList></Reference><Reference><Citation>Accattato, F. et al. Effects of acute physical exercise on oxidative stress and inflammatory status in young, sedentary obese subjects. PLOS One 12(6), e0178900. https://doi.org/10.1371/journal.pone.0178900 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0178900</ArticleId><ArticleId IdType="pubmed">28582461</ArticleId><ArticleId IdType="pmc">5459463</ArticleId></ArticleIdList></Reference><Reference><Citation>Gliemann, L., Nyberg, M. &amp; Hellsten, Y. Nitric oxide and reactive oxygen species in limb vascular function: what is the effect of physical activity? Free Radic. Res. 48 (1), 71&#x2013;83. https://doi.org/10.3109/10715762.2013.833318 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10715762.2013.833318</ArticleId><ArticleId IdType="pubmed">23962038</ArticleId></ArticleIdList></Reference><Reference><Citation>Zernecke, A., Bernhagen, J. &amp; Weber, C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation 117 (12), 1594&#x2013;1602. https://doi.org/10.1161/CIRCULATIONAHA.107.729125 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.729125</ArticleId><ArticleId IdType="pubmed">18362243</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahl, P. et al. Effects of high intensity training and high volume training on endothelial microparticles and angiogenic growth factors. PLOS One 9(4), e96024. https://doi.org/10.1371/journal.pone.0096024 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0096024</ArticleId><ArticleId IdType="pubmed">24770423</ArticleId><ArticleId IdType="pmc">4000202</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeppe Kj&#xe6;rgaard, L. et al. Mechanistic, kinetic, and cellular insights into the human lysosomal &#x3b2;-glucosidase GBA2.. PNAS 120(29), e2302597120. https://doi.org/10.1073/pnas.2302597120 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2302597120</ArticleId></ArticleIdList></Reference><Reference><Citation>Mani, B. K. et al. LEAP2 changes with body mass and food intake in humans and mice. J. Clin. Investig. 129 (9), 3909&#x2013;3923. https://doi.org/10.1172/JCI125332 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI125332</ArticleId><ArticleId IdType="pubmed">31424424</ArticleId><ArticleId IdType="pmc">6715358</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal, S., Shinar, S., Cerdeira, A., Redman, C. &amp; Vatish, M. Predictive performance of PlGF (Placental growth Factor) for screening preeclampsia in asymptomatic women: A systematic review and Meta-Analysis. HYPERTENSION 74 (5), 1124&#x2013;1135 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.119.13360</ArticleId><ArticleId IdType="pubmed">31522621</ArticleId></ArticleIdList></Reference><Reference><Citation>Mary, S. et al. Pregnancy-associated changes in urinary Uromodulin excretion in chronic hypertension. J. Nephrol. 37 (3), 597&#x2013;610 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-023-01830-6</ArticleId><ArticleId IdType="pubmed">38236469</ArticleId><ArticleId IdType="pmc">11150301</ArticleId></ArticleIdList></Reference><Reference><Citation>Bujold, E. et al. Proteomic Analysis of Maternal Urine for the Early Detection of Preeclampsia and Fetal Growth Restriction. J. Clin. Med. https://doi.org/10.3390/jcm10204679 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10204679</ArticleId><ArticleId IdType="pubmed">34682802</ArticleId><ArticleId IdType="pmc">8537852</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruickshank, T. et al. Circulating Growth Differentiation Factor 15 Is Increased Preceding Preeclampsia Diagnosis: Implications as a Disease Biomarker&#xa0;J. American Heart Assoc.&#xa0;10(16) (2021).&#xa0;</Citation></Reference><Reference><Citation>Yao, J. et al. Exosome enriched leucine-rich alpha-2-glycoprotein-1 and extracellular matrix protein 1 proteins induce abnormal placental angiogenesis in pregnant mice. PLACENTA 143, 45&#x2013;53 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2023.09.008</ArticleId><ArticleId IdType="pubmed">37804693</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">41213838</PMID><DateRevised><Year>2025</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-0528</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Nov</Month><Day>10</Day></PubDate></JournalIssue><Title>BJOG : an international journal of obstetrics and gynaecology</Title><ISOAbbreviation>BJOG</ISOAbbreviation></Journal><ArticleTitle>Prevalence of Large-for-Gestational Age and Macrosomia Among Livebirths in 23 Low- and Middle-Income Countries Between 2000 and 2021: An Individual Participant Data Analysis.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/1471-0528.70044</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine the prevalence of large-for-gestational age (LGA) and macrosomia in 23 countries between 2000 and 2021.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Descriptive multi-country secondary data analysis.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Subnational, population-based cohort studies (k&#x2009;=&#x2009;45 for LGA, k&#x2009;=&#x2009;25 for macrosomia) in 23 low- and middle-income countries (LMICs).</AbstractText><AbstractText Label="POPULATION" NlmCategory="METHODS">Liveborn infants.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a secondary analysis of individual-level data from the Vulnerable Newborn Measurement Collaboration, using INTERGROWTH-21st standards to define LGA (&gt;&#x2009;90th centile for gestational age and sex) and macrosomia (&#x2265;&#x2009;4000&#x2009;g, regardless of gestational age). We included LMIC population-based datasets with reliable gestational age and birthweight data, excluding studies with small sample sizes, high missing data, or implausible measurements. Prevalence estimates were stratified by region, study period and gestational age, and results were summarised as medians and interquartile ranges (IQR).</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Prevalence of LGA and macrosomia.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 476&#x2009;939 live births, the median prevalence of LGA was 5.1% (IQR: 2.9%-9.6%) and was highest in Latin America and the Caribbean at 9.6% (4 studies, IQR: 2.7%-16.1%) and lowest in South Asia at 2.7% (13 studies, IQR: 2.3%-3.7%). Over time, the median LGA prevalence increased from 4.9% (12 studies; IQR: 4.1%-7.9%) during the period from 2000 to 2010 to 5.9% (33 studies, IQR: 2.7%-11.2%) from 2011 to 2021. Term LGA was more common at 3.2% (0.9-5.1) than preterm or post-term LGA. Among 313&#x2009;064 live births, the median prevalence of macrosomia was 1.3% (n&#x2009;=&#x2009;313&#x2009;064, IQR: 0.2%-2.4%), which was highest in Latin America and the Caribbean (4 studies, 3.1%, IQR: 0.7%-6.8%) and lowest in South Asia (8 studies, 0.1%, IQR: 0.0%-0.7%). The median prevalence remained stable over time: 1.1% (8 studies, IQR: 0.2%-3.1%) in older studies (2000-2010) and 1.3% (17 studies, IQR: 0.5%-2.4%) in more recent studies (2011-2021). Term macrosomia was more common at 1.2% (0.2-2.0) than preterm and post-term macrosomia.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The overall prevalence of LGA and macrosomia was lower in these LMIC studies than is reported in high-income countries. The prevalence of large babies was highest in Latin America and the Caribbean.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kirakoya-Samadoulougou</LastName><ForeName>Fati</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-9584-6329</Identifier><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de Recheche en Epidemiologie, Biostatistique et Recherche Clinique, Ecole de Sant&#xe9; Publique, Universit&#xe9; Libre de Bruxelles, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ukwishaka</LastName><ForeName>Joyeuse</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre de Recheche en Epidemiologie, Biostatistique et Recherche Clinique, Ecole de Sant&#xe9; Publique, Universit&#xe9; Libre de Bruxelles, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngwasiri</LastName><ForeName>Calypse</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre de Recheche en Epidemiologie, Biostatistique et Recherche Clinique, Ecole de Sant&#xe9; Publique, Universit&#xe9; Libre de Bruxelles, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subedi</LastName><ForeName>Seema</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hazel</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0002-9176-3278</Identifier><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erchick</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0002-2852-280X</Identifier><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Lee Shu Fune</ForeName><Initials>LSF</Initials><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grandi</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Argentine Society of Paediatrics, Ciudad Aut&#xf3;noma de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lachat</LastName><ForeName>Carl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Food Technology, Safety and Health, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toe</LastName><ForeName>La&#xe9;ticia C&#xe9;line</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Food Technology, Safety and Health, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberfroid</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Namur University, Namur, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huybregts</LastName><ForeName>Lieven</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Food Technology, Safety and Health, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nutrition, Diets, and Health Unit, International Food Policy Institute, Washington, District of Colombia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labrique</LastName><ForeName>Alain B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rashid</LastName><ForeName>Mabhubur</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Noora Health, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaikh</LastName><ForeName>Saijuddin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Health Research and Development, Society for Applied Studies, Dehli, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haque</LastName><ForeName>Rezwanul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>JiVitA Maternal and Child Health Research Project, Rangpur, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baqui</LastName><ForeName>Abdullah H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saha</LastName><ForeName>Samir K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Child Health Research Foundation, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanam</LastName><ForeName>Rasheda</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Sayedur</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Projahnmo Research Foundation, Dhaka, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silveira</LastName><ForeName>Md Mari&#xe2;ngela F</ForeName><Initials>MMF</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buffarini</LastName><ForeName>Romina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>Roger L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zash</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Zhonghai</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Lingxia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Xiu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Jianrong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebreyesus</LastName><ForeName>Seifu H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Nutrition and Dietetics, School of Public Health, Addis Ababa University, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tesfamariam</LastName><ForeName>Kokeb</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Public Health, School of Medicine and Health Sciences, Ambo University, Ambo, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bekele</LastName><ForeName>Delayehu</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adu-Afarwuah</LastName><ForeName>Seth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nutrition and Food Science, University of Ghana, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dewey</LastName><ForeName>Kathryn G</ForeName><Initials>KG</Initials><AffiliationInfo><Affiliation>Institute for Global Nutrition, Department of Nutrition, University of California, Davis, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gyaase</LastName><ForeName>Stephaney</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biostatistics Unit, Kintampo Health Research Centre, Kintampo, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wylie</LastName><ForeName>Blair J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taneja</LastName><ForeName>Sunita</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Health Research and Development, Society for Applied Studies, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chowdhury</LastName><ForeName>Ranadip</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for Health Research and Development, Society for Applied Studies, New Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babu</LastName><ForeName>Giridhara R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Department of Population Medicine, College of Medicine, QU Health, Qatar University, Doha, Qatar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deepa</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>PHFI Center for Developmental and Lifecourse Research, Bengaluru, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rishard</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Obstetrics &amp; Gynaecology, University of Colombo, Colombo, Sri Lanka.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazzerini</LastName><ForeName>Marzia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", WHO Collaborating Centre for Maternal and Child Health, Trieste, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Infectious Diseases Epidemiology and International Health, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez-Sibaja</LastName><ForeName>Maria J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>National Institute of Perinatology, Maternal-Fetal Medicine Department, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acevedo-Gallegos</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Institute of Perinatology, Maternal-Fetal Medicine Department, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashorn</LastName><ForeName>Per</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maleta</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>College of Medicine, University of Malawi, Zomba, Malawi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mullany</LastName><ForeName>Luke C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jehan</LastName><ForeName>Fyezah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Paediatrcis and Child Health, The Aga Khan University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ilyas</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Aga Khan University, Karachi, Sindh, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogerson</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Doherty Institute, University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Unger</LastName><ForeName>Holger W</ForeName><Initials>HW</Initials><Identifier Source="ORCID">0000-0001-6347-536X</Identifier><AffiliationInfo><Affiliation>Menzies School of Health Research, Darwin, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7839-4148</Identifier><AffiliationInfo><Affiliation>Institute for Global Health Sciences, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musange</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Public Health, College of Medicine and Health Sciences, University of Rwanda, Butare, Rwanda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mongkolchati</LastName><ForeName>Aroonsri</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ASEAN Institute for Health Development, Mahidol University, Salaya, Nakorn Pathom, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keentupthai</LastName><ForeName>Paniya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>College of Medicine and Public Health, Ubon Ratchathani University, Ubon Ratchathani, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fawzi</LastName><ForeName>Wafaie</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dongqing</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Global and Community Health, College of Public Health, George Mason University, Fairfax, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmiegelow</LastName><ForeName>Christentze</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, Centre for Translational Medicine and Parasitology, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gynaecology and Obstetrics, Copenhagen University Hospital-North Zealand, Hilleroed, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minja</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Institute for Medical Research, Dar es Salaam, Tanzania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hjort</LastName><ForeName>Line</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculty of Health and Medical Sciences, Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics, Center for Pregnant Women with Diabetes, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lusingu</LastName><ForeName>John P A</ForeName><Initials>JPA</Initials><AffiliationInfo><Affiliation>National Institute for Medical Research, Dar es Salaam, Tanzania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Emily R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Department of Global Health, George Washington University Milken Institute School of Public Health, Washington, District of Columbia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masanja</LastName><ForeName>Honorati</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Ifakara Health Institute, Dar es Salaam, Tanzania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabole</LastName><ForeName>Fathma Mohamed</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Ministry of Health Zanzibar, Tanzania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slim</LastName><ForeName>Salim Nassir</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Ministry of Health Zanzibar, Tanzania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakuru</LastName><ForeName>Abel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectious Diseases Research Collaboration, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kajubi</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Infectious Diseases Research Collaboration, Kampala, Uganda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Dilys</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Global Health Sciences and Bixby Center for Global Reproductive Health, University of California San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waiswa</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Health Policy Planning and Management, Makerere University School of Public Health, New Mulago Hospital Complex, Kampala, Uganda.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Global Health, Department of Public Health Sciences, Karolinska Institute, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramokolo</LastName><ForeName>Vundli</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>HIV Prevention Research Unit, South African Medical Research Council, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zembe-Mkabile</LastName><ForeName>Wanga</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semrau</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-8360-1391</Identifier><AffiliationInfo><Affiliation>Ariadne Labs, Brigham and Women's Hospital and Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Global Health Equity &amp; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamer</LastName><ForeName>Davidson H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Infectious Diseases, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chico</LastName><ForeName>R Matthew</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0003-1795-7100</Identifier><AffiliationInfo><Affiliation>Department of Disease Control, Faculty of Infectious &amp; Tropical Diseases, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaponda</LastName><ForeName>Enesia Banda</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, School of Natural Sciences, University of Zambia, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manasyan</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pry</LastName><ForeName>Jake M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0001-6312-4420</Identifier><AffiliationInfo><Affiliation>Division of Epidemiology, School of Medicine, University of California, Davis, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musokotwane</LastName><ForeName>Kebby</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National HIV/AIDS/STI/TB Council of Zambia, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Bowen</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Research Unit for Environmental Sciences and Management, North-West University, Potchefstroom, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prendergast</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chasekwa</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Zvitambo Institute for Maternal and Child Health Research, Harere, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Joanne</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Anne C C</ForeName><Initials>ACC</Initials><AffiliationInfo><Affiliation>Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Robert E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Subnational Collaborative Group for Vulnerable Newborn Prevalence</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>IDINV-053360</GrantID><Agency>Bill and Melinda Gates Foundation</Agency><Country/></Grant><Grant><GrantID>200404670</GrantID><Agency>Children's Investment Fund Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BJOG</MedlineTA><NlmUniqueID>100935741</NlmUniqueID><ISSNLinking>1470-0328</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">birth weight</Keyword><Keyword MajorTopicYN="N">large&#x2010;for&#x2010;gestational age</Keyword><Keyword MajorTopicYN="N">low&#x2010; and middle&#x2010;income countries</Keyword><Keyword MajorTopicYN="N">macrosomia</Keyword><Keyword MajorTopicYN="N">vulnerable newborn types</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Ali</LastName><ForeName>Hasmot</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Christian</LastName><ForeName>Parul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klemm</LastName><ForeName>Rolf D W</ForeName><Initials>RDW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Massie</LastName><ForeName>Alan B</ForeName><Initials>AB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mitra</LastName><ForeName>Maithili</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehra</LastName><ForeName>Sucheta</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schulze</LastName><ForeName>Kerry J</ForeName><Initials>KJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shamim</LastName><ForeName>Abu Ahmed</ForeName><Initials>AA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sommer</LastName><ForeName>Alfred</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ullah</LastName><ForeName>Barkat</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>West</LastName><ForeName>Keith P</ForeName><Initials>KP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Begum</LastName><ForeName>Nazma</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chowdhury</LastName><ForeName>Nabidul Haque</ForeName><Initials>NH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Islam</LastName><ForeName>Md Shafiqul</ForeName><Initials>MS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mitra</LastName><ForeName>Dipak Kumar</ForeName><Initials>DK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quaiyum</LastName><ForeName>Abdul</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Diseko</LastName><ForeName>Modiegi</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Makhema</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yue</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guo</LastName><ForeName>Yixin</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yuan</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Roro</LastName><ForeName>Meselech</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shikur</LastName><ForeName>Bilal</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mohammed</LastName><ForeName>Yahya</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haneuse</LastName><ForeName>Sebastien</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hunegnaw</LastName><ForeName>Bezawit</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kang</LastName><ForeName>Yunhee</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Worku</LastName><ForeName>Alemayehu</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kaali</LastName><ForeName>Seyram</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Arnold</LastName><ForeName>Charles D</ForeName><Initials>CD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jack</LastName><ForeName>Darby</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Amenga-Etego</LastName><ForeName>Seeba</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hurt</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shannon</LastName><ForeName>Caitlin</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Soremekun</LastName><ForeName>Seyi</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tielsch</LastName><ForeName>James M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thulasiraj</LastName><ForeName>R D</ForeName><Initials>RD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhandari</LastName><ForeName>Nita</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martines</LastName><ForeName>Jose</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mazumder</LastName><ForeName>Sarmila</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ana</LastName><ForeName>Yamuna</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hallamaa</LastName><ForeName>Lotta</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pyykk&#xf6;</LastName><ForeName>Juha</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lumbreras-Marquez</LastName><ForeName>Mario I</ForeName><Initials>MI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mendoza-Carrera</LastName><ForeName>Claudia E</ForeName><Initials>CE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tielsch</LastName><ForeName>James M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khatry</LastName><ForeName>Subarna K</ForeName><Initials>SK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tielsch</LastName><ForeName>James M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khatry</LastName><ForeName>Subarna K</ForeName><Initials>SK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hussain</LastName><ForeName>Atiya</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karim</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kausar</LastName><ForeName>Farzana</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehmood</LastName><ForeName>Usma</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nadeem</LastName><ForeName>Naila</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nisar</LastName><ForeName>Muhammad Imran</ForeName><Initials>MI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sajid</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mueller</LastName><ForeName>Ivo</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ome-Kaius</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Butrick</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sayinzoga</LastName><ForeName>Felix</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mariani</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Urassa</LastName><ForeName>Willy</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Theander</LastName><ForeName>Thor</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deloron</LastName><ForeName>Phillippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Birgitte Bruun</ForeName><Initials>BB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Muhihi</LastName><ForeName>Alfa</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Noor</LastName><ForeName>Ramadhani Abdallah</ForeName><Initials>RA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bygbjerg</LastName><ForeName>Ib</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moeller</LastName><ForeName>Sofie Lykke</ForeName><Initials>SL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aftab</LastName><ForeName>Fahad</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ali</LastName><ForeName>Said M</ForeName><Initials>SM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dhingra</LastName><ForeName>Pratibha</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dhingra</LastName><ForeName>Usha</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dutta</LastName><ForeName>Arup</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sazawal</LastName><ForeName>Sunil</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Suleiman</LastName><ForeName>Atifa</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mohammed</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Deb</LastName><ForeName>Saikat</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kamya</LastName><ForeName>Moses R</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nakalembe</LastName><ForeName>Miriam</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mulowooz</LastName><ForeName>Jude</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santos</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biemba</LastName><ForeName>Godfrey</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Herlihy</LastName><ForeName>Julie M</ForeName><Initials>JM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mbewe</LastName><ForeName>Reuben K</ForeName><Initials>RK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hamomba</LastName><ForeName>Fern Mweene</ForeName><Initials>FM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yeboah-Antwi</LastName><ForeName>Kojo</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bruce</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chandramohan</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>11</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>11</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>10</Day><Hour>21</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41213838</ArticleId><ArticleId IdType="doi">10.1111/1471-0528.70044</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>L. Su&#xe1;rez&#x2010;Idueta, J. Yargawa, H. Blencowe, et&#xa0;al., &#x201c;Vulnerable Newborn Types: Analysis of Population&#x2010;Based Registries for 165 Million Births in 23 Countries, 2000&#x2013;2021,&#x201d; BJOG: An International Journal of Obstetrics &amp; Gynaecology (2023): 1&#x2013;15.</Citation></Reference><Reference><Citation>L. Su&#xe1;rez&#x2010;Idueta, H. Blencowe, Y. B. Okwaraji, et&#xa0;al., &#x201c;Neonatal Mortality Risk for Vulnerable Newborn Types in 15 Countries Using 125.5 Million Nationwide Birth Outcome Records, 2000&#x2013;2020,&#x201d; BJOG: An International Journal of Obstetrics and Gynaecology (2023): 1&#x2013;11.</Citation></Reference><Reference><Citation>E. A. Hazel, D. J. Erchick, J. Katz, et&#xa0;al., &#x201c;Neonatal Mortality Risk of Vulnerable Newborns: A Descriptive Analysis of Subnational, Population&#x2010;Based Birth Cohorts for 238 203 Live Births in Low&#x2010; and Middle&#x2010;Income Settings From 2000 to 2017,&#x201d; BJOG: An International Journal of Obstetrics and Gynaecology (2023): 1&#x2013;12.</Citation></Reference><Reference><Citation>S. K. Ng, A. Olog, A. B. Spinks, C. M. Cameron, J. Searle, and R. J. McClure, &#x201c;Risk Factors and Obstetric Complications of Large for Gestational Age Births With Adjustments for Community Effects: Results From a New Cohort Study,&#x201d; BMC Public Health 10 (2010): 460.</Citation></Reference><Reference><Citation>C. Mayer and K. S. Joseph, &#x201c;Fetal Growth: A Review of Terms, Concepts and Issues Relevant to Obstetrics,&#x201d; Ultrasound in Obstetrics &amp; Gynecology 41, no. 2 (2013): 136&#x2013;145.</Citation></Reference><Reference><Citation>A. Z. Khambalia, C. S. Algert, J. R. Bowen, R. J. Collie, and C. L. Roberts, &#x201c;Long&#x2010;Term Outcomes for Large for Gestational Age Infants Born at Term,&#x201d; Journal of Paediatrics and Child Health 53, no. 9 (2017): 876&#x2013;881.</Citation></Reference><Reference><Citation>H. Nordman, J. J&#xe4;&#xe4;skel&#xe4;inen, and R. Voutilainen, &#x201c;Birth Size as a Determinant of Cardiometabolic Risk Factors in Children,&#x201d; Hormone Research in P&#xe6;diatrics 93 (2020): 144&#x2013;153.</Citation></Reference><Reference><Citation>V. Chiavaroli, J. G. B. Derraik, P. L. Hofman, and W. S. Cutfield, &#x201c;Born Large for Gestational Age: Bigger Is Not Always Better,&#x201d; Journal of Pediatrics 170 (2016): 307&#x2013;311.</Citation></Reference><Reference><Citation>X. Lei, D. Zhao, L. Huang, et&#xa0;al., &#x201c;Childhood Health Outcomes in Term, Large&#x2010;For&#x2010;Gestational&#x2010;Age Babies With Different Postnatal Growth Patterns,&#x201d; American Journal of Epidemiology 187, no. 3 (2018): 507&#x2013;514.</Citation></Reference><Reference><Citation>Y. H. Hong and J. E. Lee, &#x201c;Large for Gestational Age and Obesity&#x2010;Related Comorbidities,&#x201d; Journal of Obesity &amp; Metabolic Syndrome 30, no. 2 (2021): 124&#x2013;131.</Citation></Reference><Reference><Citation>J. G. B. Derraik, S. E. Maessen, J. D. Gibbins, W. S. Cutfield, M. Lundgren, and F. Ahlsson, &#x201c;Large&#x2010;For&#x2010;Gestational&#x2010;Age Phenotypes and Obesity Risk in Adulthood: A Study of 195,936 Women,&#x201d; Scientific Reports 10, no. 1 (2020): 2157.</Citation></Reference><Reference><Citation>A. Suhag, A. Rerkasem, K. Kulprachakarn, et&#xa0;al., &#x201c;Long&#x2010;Term Health Associated With Small and Large for Gestational Age Births Among Young Thai Adults,&#x201d; Children (Basel) 9, no. 6 (2022): 779.</Citation></Reference><Reference><Citation>C. M. Scifres, &#x201c;Short&#x2010; and Long&#x2010;Term Outcomes Associated With Large for Gestational Age Birth Weight,&#x201d; Obstetrics and Gynecology Clinics of North America 48, no. 2 (2021): 325&#x2013;337.</Citation></Reference><Reference><Citation>S. L. Boulet, G. R. Alexander, H. M. Salihu, and M. Pass, &#x201c;Macrosomic Births in the United States: Determinants, Outcomes, and Proposed Grades of Risk,&#x201d; American Journal of Obstetrics and Gynecology 188, no. 5 (2003): 1372&#x2013;1378.</Citation></Reference><Reference><Citation>K. McMurrugh, M. C. Vieira, and S. Sankaran, &#x201c;Fetal Macrosomia and Large for Gestational Age,&#x201d; Obstetrics, Gynaecology and Reproductive Medicine 34, no. 3 (2024): 66&#x2013;72.</Citation></Reference><Reference><Citation>S. E. Damhuis, W. Ganzevoort, and S. J. Gordijn, &#x201c;Abnormal Fetal Growth: Small for Gestational Age, Fetal Growth Restriction, Large for Gestational Age: Definitions and Epidemiology,&#x201d; Obstetrics and Gynecology Clinics of North America 48, no. 2 (2021): 267&#x2013;279.</Citation></Reference><Reference><Citation>M. C. Dennedy and F. Dunne, &#x201c;Macrosomia: Defining the Problem Worldwide,&#x201d; Lancet 381, no. 9865 (2013): 435&#x2013;436.</Citation></Reference><Reference><Citation>H. Xu, F. Simonet, and Z. C. Luo, &#x201c;Optimal Birth Weight Percentile Cut&#x2010;Offs in Defining Small&#x2010; or Large&#x2010;For&#x2010;Gestational&#x2010;Age,&#x201d; Acta Paediatrica 99, no. 4 (2010): 550&#x2013;555.</Citation></Reference><Reference><Citation>Y. B. Zhao and D. Z. Li, &#x201c;Born Large for Gestational Age: Not Just Bigger,&#x201d; American Journal of Obstetrics and Gynecology 228, no. 3 (2023): 366&#x2013;367.</Citation></Reference><Reference><Citation>M. W. Lwin, E. Timby, A. Ivarsson, et&#xa0;al., &#x201c;Abnormal Birth Weights for Gestational Age in Relation to Maternal Characteristics in Sweden: A Five Year Cross&#x2010;Sectional Study,&#x201d; BMC Public Health 23, no. 1 (2023): 976.</Citation></Reference><Reference><Citation>V. Chiavaroli, V. Castorani, P. Guidone, et&#xa0;al., &#x201c;Incidence of Infants Born Small&#x2010; and Large&#x2010;For&#x2010;Gestational&#x2010;Age in an Italian Cohort Over a 20&#x2010;Year Period and Associated Risk Factors,&#x201d; Italian Journal of Pediatrics 42 (2016): 42.</Citation></Reference><Reference><Citation>S. Younes, M. Samara, N. Salama, et&#xa0;al., &#x201c;Incidence, Risk Factors, and Feto&#x2010;Maternal Outcomes of Inappropriate Birth Weight for Gestational Age Among Singleton Live Births in Qatar: A Population&#x2010;Based Study,&#x201d; PLoS One 16 (2021): e0258967.</Citation></Reference><Reference><Citation>S. Mustaniemi, H. Nikkinen, A. Bloigu, et&#xa0;al., &#x201c;Normal Gestational Weight Gain Protects From Large&#x2010;For&#x2010;Gestational&#x2010;Age Birth Among Women With Obesity and Gestational Diabetes,&#x201d; Frontiers in Public Health 9 (2021): 550860.</Citation></Reference><Reference><Citation>M. C. Vieira, S. Relph, M. Persson, P. T. Seed, and D. Pasupathy, &#x201c;Determination of Birth&#x2010;Weight Centile Thresholds Associated With Adverse Perinatal Outcomes Using Population, Customised, and Intergrowth Charts: A Swedish Population&#x2010;Based Cohort Study,&#x201d; PLoS Medicine 16, no. 9 (2019): e1002902.</Citation></Reference><Reference><Citation>J. Villar, F. Giuliani, T. R. Fenton, E. O. Ohuma, L. C. Ismail, and S. H. Kennedy, &#x201c;INTERGROWTH&#x2010;21st Very Preterm Size at Birth Reference Charts,&#x201d; Lancet 387, no. 10021 (2016): 844&#x2013;845.</Citation></Reference><Reference><Citation>A. Hocquette, M. Durox, R. Wood, et&#xa0;al., &#x201c;International Versus National Growth Charts for Identifying Small and Large&#x2010;For&#x2010;Gestational Age Newborns: A Population&#x2010;Based Study in 15 European Countries,&#x201d; Lancet Regional Health&#x2013;Europe 8 (2021): 100167.</Citation></Reference><Reference><Citation>S. K. Y. Choi, A. Gordon, L. Hilder, et&#xa0;al., &#x201c;Performance of Six Birth&#x2010;Weight and Estimated&#x2010;Fetal&#x2010;Weight Standards for Predicting Adverse Perinatal Outcome: A 10&#x2010;Year Nationwide Population&#x2010;Based Study,&#x201d; Ultrasound in Obstetrics &amp; Gynecology 58, no. 2 (2021): 264&#x2013;277.</Citation></Reference><Reference><Citation>A. Koyanagi, J. Zhang, A. Dagvadorj, et&#xa0;al., &#x201c;Macrosomia in 23 Developing Countries: An Analysis of a Multicountry, Facility&#x2010;Based, Cross&#x2010;Sectional Survey,&#x201d; Lancet 381, no. 9865 (2013): 476&#x2013;483.</Citation></Reference><Reference><Citation>D. J. Erchick, E. A. Hazel, J. Katz, et&#xa0;al., &#x201c;Vulnerable Newborn Types: Analysis of Subnational, Population&#x2010;Based Birth Cohorts for 541 285 Live Births in 23 Countries, 2000&#x2013;2021,&#x201d; BJOG: An International Journal of Obstetrics and Gynaecology (2023): 1&#x2013;17.</Citation></Reference><Reference><Citation>N. P. Deputy, P. H. Nguyen, H. Pham, et&#xa0;al., &#x201c;Validity of Gestational Age Estimates by Last Menstrual Period and Neonatal Examination Compared to Ultrasound in Vietnam,&#x201d; BMC Pregnancy and Childbirth 17, no. 1 (2017): 25.</Citation></Reference><Reference><Citation>M. Whitworth, L. Bricker, J. P. Neilson, and T. Dowswell, &#x201c;Ultrasound for Fetal Assessment in Early Pregnancy,&#x201d; Cochrane Database of Systematic Reviews, no. 4 (2010): CD007058.</Citation></Reference><Reference><Citation>C. D. Lynch and J. Zhang, &#x201c;The Research Implications of the Selection of a Gestational Age Estimation Method,&#x201d; Paediatric and Perinatal Epidemiology 21, no. Suppl 2 (2007): 86&#x2013;96.</Citation></Reference><Reference><Citation>A. Patel, C. M. Bann, V. R. Thorsten, et&#xa0;al., &#x201c;Can the Date of Last Menstrual Period Be Trusted in the First Trimester? Comparisons of Gestational Age Measures From a Prospective Cohort Study in Six Low&#x2010;Income to Middle&#x2010;Income Countries,&#x201d; BMJ Open 13, no. 9 (2023): e067470.</Citation></Reference><Reference><Citation>D. A. Savitz, J. W. Terry, N. Dole, J. M. Thorp, A. M. Siega&#x2010;Riz, and A. H. Herring, &#x201c;Comparison of Pregnancy Dating by Last Menstrual Period, Ultrasound Scanning, and Their Combination,&#x201d; American Journal of Obstetrics and Gynecology 187, no. 6 (2002): 1660&#x2013;1666.</Citation></Reference><Reference><Citation>C. S. Yajnik, &#x201c;The Lifecycle Effects of Nutrition and Body Size on Adult Adiposity, Diabetes and Cardiovascular Disease,&#x201d; Obesity Reviews 3, no. 3 (2002): 217&#x2013;224.</Citation></Reference><Reference><Citation>A. Khalili Doroodzani, S. Dobaradaran, E. Rahmani, et&#xa0;al., &#x201c;A Comparative Monitoring of Maternal and Cord Serum Polychlorinated Biphenyls Levels From Iranian Pregnant Women Between Industrial and Urban Areas,&#x201d; Environmental Pollution 317 (2023): 120781.</Citation></Reference><Reference><Citation>A. Khalili Doroodzani, S. Dobaradaran, R. Akhbarizadeh, et&#xa0;al., &#x201c;Diet, Exposure to Polycyclic Aromatic Hydrocarbons During Pregnancy, and Fetal Growth: A Comparative Study of Mothers and Their Fetuses in Industrial and Urban Areas in Southwest Iran,&#x201d; Environmental Pollution 276 (2021): 116668.</Citation></Reference><Reference><Citation>X. Chen, H. Orom, J. L. Hay, et&#xa0;al., &#x201c;Differences in Rural and Urban Health Information Access and Use,&#x201d; Journal of Rural Health 35, no. 3 (2019): 405&#x2013;417.</Citation></Reference><Reference><Citation>H. M. Bizuayehu, M. L. Harris, C. Chojenta, G. T. Kiross, and D. Loxton, &#x201c;Maternal Residential Area Effects on Preterm Birth, Low Birth Weight and Caesarean Section in Australia: A Systematic Review,&#x201d; Midwifery 123 (2023): 103704.</Citation></Reference><Reference><Citation>A. Tb and M. Ya, &#x201c;Prevalence of Preterm Birth and Associated Factors Among Mothers Who Gave Birth in Public Hospitals of East Gojjam Zone, Ethiopia,&#x201d; BMC Pregnancy and Childbirth 23, no. 1 (2023): 204.</Citation></Reference><Reference><Citation>V. Mehrnoush, A. Ranjbar, F. Banihashemi, F. Darsareh, M. Shekari, and M. Shirzadfardjahromi, &#x201c;Urban&#x2010;Rural Differences in the Pregnancy&#x2010;Related Adverse Outcome,&#x201d; Gynecology and Obstetrics Clinical Medicine 3, no. 1 (2023): 51&#x2013;55.</Citation></Reference><Reference><Citation>C. Qin, J. Hsia, and C. J. Berg, &#x201c;Variation Between Last&#x2010;Menstrual&#x2010;Period and Clinical Estimates of Gestational Age in Vital Records,&#x201d; American Journal of Epidemiology 167, no. 6 (2008): 646&#x2013;652.</Citation></Reference><Reference><Citation>Y. W. Wang, Y. Chen, and Y. J. Zhang, &#x201c;Risk Factors Combine in a Complex Manner in Assessment for Macrosomia,&#x201d; BMC Public Health 23, no. 1 (2023): 271.</Citation></Reference><Reference><Citation>D. G. Adugna, E. F. Enyew, and M. T. Jemberie, &#x201c;Prevalence and Associated Factors of Macrosomia Among Newborns Delivered in University of Gondar Comprehensive Specialized Hospital, Gondar, Ethiopia: An Institution&#x2010;Based Cross&#x2010;Sectional Study,&#x201d; Pediatric Health, Medicine and Therapeutics 11 (2020): 495&#x2013;503.</Citation></Reference><Reference><Citation>M. Malik, P. Khanna, and R. Verma, &#x201c;The Association of Maternal Risk Factors to Macrosomia in Rural Areas of Haryana, India: A Community&#x2010;Based Study,&#x201d; International Journal of Community Medicine and Public Health 5, no. 9 (2018): 3842&#x2013;3846.</Citation></Reference><Reference><Citation>L. Harvey, R. van Elburg, and E. M. van der Beek, &#x201c;Macrosomia and Large for Gestational Age in Asia: One Size Does Not Fit All,&#x201d; Journal of Obstetrics and Gynaecology Research 47, no. 6 (2021): 1929&#x2013;1945.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">41213790</PMID><DateRevised><Year>2025</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-6263</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Taiwanese journal of obstetrics &amp; gynecology</Title><ISOAbbreviation>Taiwan J Obstet Gynecol</ISOAbbreviation></Journal><ArticleTitle>Effect of low-dose aspirin in women with pregestational diabetes mellitus: A propensity score matching study.</ArticleTitle><Pagination><StartPage>985</StartPage><EndPage>989</EndPage><MedlinePgn>985-989</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tjog.2024.11.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1028-4559(25)00243-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Aspirin is recommended for women with pregestational diabetes mellitus (PGDM) because they are at a high risk for preeclampsia. However, previous studies have predominantly examined the effect of aspirin on high-risk groups, with few investigations of its effect on PGDM alone. Therefore, the aim of this study was to investigate the overall efficacy and safety of low-dose aspirin in women with PGDM.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">The dataset consisted of 40,713 records of women who received antenatal care between January 2011 and December 2021 at eight hospitals in different regions. We excluded patients who were not diagnosed with PGDM, had multiple pregnancies, had absent newborn records, were prescribed aspirin for less than 30 days, and had a dose of aspirin less than 100 mg during pregnancy. In total, 207 patients with PGDM were included in the analysis. We further excluded patients in whom aspirin was initiated at an unknown gestational age. To address the potential for selection bias and confounding variables, we employed propensity score matching (PSM) using the "nearest neighbor" method.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our study included 192 patients (aspirin group: N = 37; control group: N = 155). No difference was observed in maternal prognosis between the aspirin and control groups. Aspirin did not prevent preeclampsia, fetal growth restriction, or preterm birth. However, the aspirin group exhibited a higher rate of large-for-gestational-age (LGA) births than the control group (41 % vs. 16 %, p = 0.02). No significant obstetric differences were observed between the aspirin and control groups. In multivariate logistic regression analysis, LGA births were significantly associated with aspirin treatment (Odds ratio 3.51, 95 % confidence interval: 1.16-11.8).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The use of low-dose aspirin in women with PGDM may be associated with an increased risk of LGA births. Because of the retrospective nature of this study, a large-scale prospective study is needed to verify these results.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seon Ui</ForeName><Initials>SU</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Sae Kyung</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Ju Myung</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Jinseon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, South Korea; Pharmacometrics Institute for Practical Education and Training (PIPET), College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Suein</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, South Korea; Pharmacometrics Institute for Practical Education and Training (PIPET), College of Medicine, The Catholic University of Korea, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Seunghoon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, South Korea; Pharmacometrics Institute for Practical Education and Training (PIPET), College of Medicine, The Catholic University of Korea, Seoul, South Korea. Electronic address: waystolove@catholic.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>In Yang</ForeName><Initials>IY</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. Electronic address: ooooobbbbb@catholic.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China (Republic : 1949- )</Country><MedlineTA>Taiwan J Obstet Gynecol</MedlineTA><NlmUniqueID>101213819</NlmUniqueID><ISSNLinking>1028-4559</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aspirin</Keyword><Keyword MajorTopicYN="N">Maternal large-for-gestational-age infant</Keyword><Keyword MajorTopicYN="N">Pregestational diabetes mellitus</Keyword><Keyword MajorTopicYN="N">Propensity score matching</Keyword></KeywordList><CoiStatement>Declarations of interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>11</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>11</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>10</Day><Hour>20</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41213790</ArticleId><ArticleId IdType="doi">10.1016/j.tjog.2024.11.014</ArticleId><ArticleId IdType="pii">S1028-4559(25)00243-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">41213472</PMID><DateRevised><Year>2025</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3840</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Nov</Month><Day>08</Day></PubDate></JournalIssue><Title>Canadian journal of diabetes</Title><ISOAbbreviation>Can J Diabetes</ISOAbbreviation></Journal><ArticleTitle>Causal relationship between multiple modifiable risk factors and gestational diabetes mellitus: a two-sample Mendelian randomization study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1499-2671(25)00394-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcjd.2025.10.178</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Gestational Diabetes Mellitus (GDM) is a significant metabolic disorder affecting pregnant women, leading to increased risks of adverse maternal and fetal outcomes. Effective management and preventive strategies are crucial to mitigate its short- and long-term complications.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to elucidate the causal relationships between multiple modifiable risk factors and GDM using a two-sample Mendelian randomization (MR) approach.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed 41 modifiable risk factors, categorized into metabolic and weight factors, dietary habits, smoking and alcohol behaviors, and physical activities. Genetic variants associated with these risk factors were identified from genome-wide association studies (GWAS). GDM data came from the largest GWAS on gestational diabetes, including 12,332 GDM cases and 131,109 Finnish ancestry controls from the FinnGen study. MR analysis was performed using inverse variance weighted (IVW), MR-Egger, weighted median, simple mode, and weighted mode methods.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Preliminary screening identified 12 significant modifiable risk factors, with fasting glucose, fasting insulin, glycated hemoglobin levels, triglycerides, body mass index (BMI), two-hour glucose, and processed meat intake increasing GDM risk, while high-density lipoprotein (HDL) cholesterol, tea consumption, cheese intake, lamb/mutton intake, and dried fruit intake decreased the risk. After correction for multiple comparisons, fasting glucose, fasting insulin, glycated hemoglobin levels, triglycerides, BMI, and HDL cholesterol remained significant and consistent across various methods.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This comprehensive MR study provides strong evidence for the causal effects of various modifiable risk factors on GDM, highlighting the importance of lifestyle interventions targeting metabolic and dietary factors to prevent GDM and improve maternal and fetal outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Chung-Chih</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Integrated Chinese and Western Medicine, Chung Shan Medical University Hospital, Taichung 40242, Taiwan; Department of Post-Baccalaureate Veterinary Medicine, College of Medical and Health Science, Asia University, Taichung 41354, Taiwan. Electronic address: cshy2232@csh.org.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chun-I</ForeName><Initials>CI</Initials><AffiliationInfo><Affiliation>School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan; Division of Infertility, Lee Women's Hospital, Taichung 40652, Taiwan; Department of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan. Electronic address: adoctor0402@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jung-Miao</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung 40402, Taiwan; Department of Chinese Medicine, China Medical University Hospital, Taichung 40447, Taiwan. Electronic address: jmli@mail.cmu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Can J Diabetes</MedlineTA><NlmUniqueID>101148810</NlmUniqueID><ISSNLinking>1499-2671</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mendelian randomization</Keyword><Keyword MajorTopicYN="N">genetic variants</Keyword><Keyword MajorTopicYN="N">gestational diabetes mellitus</Keyword><Keyword MajorTopicYN="N">modifiable risk factors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>11</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>11</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>10</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41213472</ArticleId><ArticleId IdType="doi">10.1016/j.jcjd.2025.10.178</ArticleId><ArticleId IdType="pii">S1499-2671(25)00394-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">41208570</PMID><DateRevised><Year>2025</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1463-1326</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Nov</Month><Day>10</Day></PubDate></JournalIssue><Title>Diabetes, obesity &amp; metabolism</Title><ISOAbbreviation>Diabetes Obes Metab</ISOAbbreviation></Journal><ArticleTitle>Five years liraglutide treatment improves glucose tolerance in women with previous gestational diabetes mellitus-Results from a randomised controlled trial.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/dom.70286</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Emilie S</ForeName><Initials>ES</Initials><Identifier Source="ORCID">0000-0001-7466-9055</Identifier><AffiliationInfo><Affiliation>Copenhagen University Hospital-Steno Diabetes Center Copenhagen, Herlev, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foghsgaard</LastName><ForeName>Signe</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1600-3145</Identifier><AffiliationInfo><Affiliation>Copenhagen University Hospital-Steno Diabetes Center Copenhagen, Herlev, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gynaecology and Obstetrics, Herlev Hospital, University of Copenhagen, Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vedtofte</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Copenhagen University Hospital-Steno Diabetes Center Copenhagen, Herlev, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Marie H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Copenhagen University Hospital-Steno Diabetes Center Copenhagen, Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forman</LastName><ForeName>Julie L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Public Health, Section of Biostatistics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strandberg</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svare</LastName><ForeName>Jens A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Gynaecology and Obstetrics, Herlev Hospital, University of Copenhagen, Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clausen</LastName><ForeName>Tine D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Department of Gynaecology and Obstetrics, University Hospital of Zealand, Roskilde, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathiesen</LastName><ForeName>Elisabeth R</ForeName><Initials>ER</Initials><Identifier Source="ORCID">0000-0003-3279-0863</Identifier><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Pregnant Women with Diabetes, Department of Endocrinology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damm</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Pregnant Women with Diabetes, Department of Obstetrics, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holst</LastName><ForeName>Jens J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0001-6853-3805</Identifier><AffiliationInfo><Affiliation>Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knop</LastName><ForeName>Filip K</ForeName><Initials>FK</Initials><Identifier Source="ORCID">0000-0002-2495-5034</Identifier><AffiliationInfo><Affiliation>Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilsb&#xf8;ll</LastName><ForeName>Tina</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-0456-6787</Identifier><AffiliationInfo><Affiliation>Copenhagen University Hospital-Steno Diabetes Center Copenhagen, Herlev, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>The Aase og Ejnar Danielsen's Foundation</Agency><Country/></Grant><Grant><Agency>Danish Diabetes and Endocrine Academy</Agency><Country/></Grant><Grant><Agency>Novo Nordisk</Agency><Country/></Grant><Grant><Agency>A.P. M&#xf8;ller og Hustru Chastine Mc-Kinney M&#xf8;llers Fond til almene Formaal</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Diabetes Obes Metab</MedlineTA><NlmUniqueID>100883645</NlmUniqueID><ISSNLinking>1462-8902</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diabetes mellitus</Keyword><Keyword MajorTopicYN="N">gestational</Keyword><Keyword MajorTopicYN="N">glucagon&#x2010;like peptide 1 receptor agonists</Keyword><Keyword MajorTopicYN="N">glucose intolerance</Keyword><Keyword MajorTopicYN="N">prediabetes</Keyword><Keyword MajorTopicYN="N">prevention</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>10</Day><Hour>4</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41208570</ArticleId><ArticleId IdType="doi">10.1111/dom.70286</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47. doi:10.1038/s41572&#x2010;019&#x2010;0098&#x2010;8</Citation></Reference><Reference><Citation>Kitzmiller JL, Dang&#x2010;Kilduff L, Taslimi MM. Gestational diabetes after delivery: short&#x2010;term management and long&#x2010;term risks. Diabetes Care. 2007;30(Supplement 2):S225&#x2010;S235. doi:10.2337/dc07&#x2010;s221</Citation></Reference><Reference><Citation>Dennison RA, Oliver&#x2010;Williams C, Qi HLJ, et al. The effectiveness of pharmacological and lifestyle interventions to reduce the risk of diabetes and hyperglycaemia following gestational diabetes: a systematic review and meta&#x2010;analysis. Diabet Med. 2024;41(6):e15316. doi:10.1111/dme.15316</Citation></Reference><Reference><Citation>Elkind&#x2010;Hirsch KE, Shaler D, Harris R. Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight/obese women with recent gestational diabetes: a double&#x2010;blind, randomized, placebo&#x2010;controlled study. J Diabetes Complications. 2020;34(4):107548. doi:10.1016/j.jdiacomp.2020.107548</Citation></Reference><Reference><Citation>Blonde L, Russell&#x2010;Jones D. The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1&#x2010;5 studies. Diabetes Obes Metab. 2009;11(Suppl 3):26&#x2010;34. doi:10.1111/j.1463&#x2010;1326.2009.01075.x</Citation></Reference><Reference><Citation>le Roux CW, Astrup A, Fujioka K, et al. 3&#x2009;years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double&#x2010;blind trial. Lancet. 2017;389(10077):1399&#x2010;1409. doi:10.1016/S0140&#x2010;6736(17)30069&#x2010;7</Citation></Reference><Reference><Citation>Foghsgaard S, Vedtofte L, Andreasen C, et al. Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect. Diabetologia. 2017;60(7):1344&#x2010;1353. doi:10.1007/s00125&#x2010;017&#x2010;4265&#x2010;8</Citation></Reference><Reference><Citation>Foghsgaard S, Vedtofte L, Andersen ES, et al. Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: a 52&#x2010;week randomized controlled clinical trial. Diabetes Obes Metab. 2023;26(1):201&#x2010;214. doi:10.1111/dom.15306</Citation></Reference><Reference><Citation>Foghsgaard S, Vedtofte L, Mathiesen ER, et al. The effect of a glucagon&#x2010;like peptide&#x2010;1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator&#x2010;initiated, randomised, placebo&#x2010;controlled, double&#x2010;blinded, parallel intervention trial. BMJ Open. 2013;3(10):e003834. doi:10.1136/bmjopen&#x2010;2013&#x2010;003834</Citation></Reference><Reference><Citation>Danish Society of Obstetrics and Gynaecology. National Guideline Report: Gestational Diabetes Mellitus: Screening and Diagnosis. 2014. Accessed May 10, 2024. https.//gynobsguideline.dk/wp/wp&#x2010;content/uploads/2013/02/GDM&#x2010;Sandbjerg&#x2010;2014&#x2010;godkendt&#x2010;2014.pdf</Citation></Reference><Reference><Citation>Bagger JI, Knop FK, Lund A, Vestergaard H, Holst JJ, Vilsb&#xf8;ll T. Impaired regulation of the incretin effect in patients with type 2 diabetes. J Clin Endocrinol Metab. 2011;96(3):737&#x2010;745. doi:10.1210/jc.2010&#x2010;2435</Citation></Reference><Reference><Citation>Daniele G, Tura A, Dardano A, et al. Effects of treatment with metformin and/or sitagliptin on beta&#x2010;cell function and insulin resistance in prediabetic women with previous gestational diabetes. Diabetes Obes Metab. 2020;22(4):648&#x2010;657. doi:10.1111/dom.13940</Citation></Reference><Reference><Citation>Vilsb&#xf8;ll T, Knop FK. Therapy: Liraglutide&#x2014;preventing or postponing T2DM diagnosis? Nat Rev Endocrinol. 2017;13(6):320&#x2010;322. doi:10.1038/nrendo.2017.55</Citation></Reference><Reference><Citation>Knop FK, Aaboe K, Vilsb&#xf8;ll T, et al. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity. Diabetes Obes Metab. 2012;14(6):500&#x2010;510. doi:10.1111/j.1463&#x2010;1326.2011.01549.x</Citation></Reference><Reference><Citation>Knop FK, Vilsb&#xf8;ll T, H&#xf8;jberg PV, et al. Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state? Diabetes. 2007;56(8):1951&#x2010;1959. doi:10.2337/db07&#x2010;0100</Citation></Reference><Reference><Citation>Kosinski M, Knop FK, Vedtofte L, et al. Postpartum reversibility of impaired incretin effect in gestational diabetes mellitus. Regul Pept. 2013;186:104&#x2010;107. doi:10.1016/j.regpep.2013.08.002</Citation></Reference><Reference><Citation>Michalopoulou M, Piernas C, Jebb SA, Gao M, Astbury NM. Association of gestational diabetes with long&#x2010;term risk of premature mortality, and cardiovascular outcomes and risk factors: a retrospective cohort analysis in the UK Biobank. Diabetes Obes Metab. 2024;26(7):2915&#x2010;2924. doi:10.1111/dom.15612</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>